Baxter Healthcare Corporation recalls REVACLEAR 300 Dialyzer, Product Code 114745L Revaclear 300 and Revaclear 400 dialyzers are indicated for treatment of c…
- Recall date
- May 31, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1908-2019
- FDA classification
- Class II
- Brand / firm
- Baxter Healthcare Corporation
- Sold / distributed
- US Nationwide Distribution and Internationally to: Canada and Bermuda.
Why it was recalled
There is a potential presence of ruptured dialyzer fibers which may lead to a blood leak during treatment.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
REVACLEAR 300 Dialyzer, Product Code 114745L Revaclear 300 and Revaclear 400 dialyzers are indicated for treatment of chronic and acute renal failure by hemodialysis.
Get recall alerts
Free email alert whenever Baxter Healthcare Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Baxter Healthcare Corporation